Full Text View
Tabular View
No Study Results Posted
Related Studies
Olmesartan and an Add-on Treatment in Patients With Mild to Moderate Hypertension (OLMETREAT)
This study has been completed.
Study NCT00311155   Information provided by Daiichi Sankyo Inc.
First Received: April 3, 2006   Last Updated: April 28, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Essential Hypertension
Additional conditions recognized in this trial
Hypertension
More general conditions related to this trial
Cardiovascular Diseases
Vascular Diseases
Additional drug interventions recognized in this trial
Amlodipine
Hydrochlorothiazide
Olmesartan medoxomil
More general drug interventions related to this trial
Angiotensin II Type 1 Receptor Blockers
Antihypertensive Agents
Calcium Channel Blockers
Cardiovascular Agents
Diuretics
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Natriuretic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sodium Chloride Symporter Inhibitors
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
Sankyo Pharma Gmbh


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services